Renaissance Technologies
CODX

Renaissance Technologies’s Co-Diagnostics CODX Stock Holding History

Renaissance Technologies’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,344
Closed -$123K – 3317
2025
Q4 		$123K Sell
24,344
-4,573
-16% -$49.8K ﹤0.01% 2973
2025
Q3 		$298K Buy
28,917
+10,216
+55% +$95K ﹤0.01% 3000
2025
Q2 		$157K Buy
18,701
+357
+2% +$3.34K ﹤0.01% 3211
2025
Q1 		$170K Sell
18,344
-177
-1% -$3.38K ﹤0.01% 3109
2024
Q4 		$417K Sell
18,521
-403
-2% -$12.7K ﹤0.01% 2925
2024
Q3 		$710K Sell
18,924
-643
-3% -$24.7K ﹤0.01% 2626
2024
Q2 		$734K Sell
19,567
-446
-2% -$16.2K ﹤0.01% 2494
2024
Q1 		$672K Sell
20,013
-554
-3% -$20.1K ﹤0.01% 2729
2023
Q4 		$821K Sell
20,567
-646
-3% -$22.8K ﹤0.01% 2528
2023
Q3 		$675K Sell
21,213
-577
-3% -$21.8K ﹤0.01% 2563
2023
Q2 		$726K Buy
21,790
+180
+0.8% +$6.89K ﹤0.01% 2674
2023
Q1 		$959K Sell
21,610
-197
-0.9% -$15.8K ﹤0.01% 2508
2022
Q4 		$1.65M Sell
21,807
-1,686
-7% -$158K ﹤0.01% 2198
2022
Q3 		$2.26M Buy
23,493
+710
+3% +$99.3K ﹤0.01% 1935
2022
Q2 		$3.83M Buy
22,783
+3,248
+17% +$494K ﹤0.01% 1751
2022
Q1 		$3.62M Buy
19,535
+9,718
+99% +$2.01M ﹤0.01% 1804
2021
Q4 		$2.63M Buy
9,817
+3,667
+60% +$962K ﹤0.01% 1942
2021
Q3 		$1.79M Buy
6,150
+4,107
+201% +$1.2M ﹤0.01% 2170
2021
Q2 		$506K Buy
+2,043
New +$525K ﹤0.01% 2962
2020
Q1 		– Sell
-534
Closed -$14K – 3478
2019
Q4 		$14K Buy
+534
New +$15.7K ﹤0.01% 3457

Other funds holding CODX

PAG
Private Advisory Group Redmond, Washington $1.52B AUM 41.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SAM
Smartleaf Asset Management Boston, Massachusetts $2.77B AUM 22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
HWA
Heritage Wealth Advisors Richmond, Virginia $2.56B AUM 19.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Renaissance Technologies's CODX Position: Q1 2026 in Review

Renaissance Technologies sold out of Co-Diagnostics (CODX) in Q1 2026, closing a stake of 24,344 shares — an estimated $123K sold.

Renaissance Technologies first reported a position in CODX in Q4 2019 and held it in 20 quarters. The position peaked at $3.83M in Q2 2022. 14 funds tracked by Wall St. Rank hold CODX as of Q1 2026.

  • Renaissance Technologies reported no remaining Co-Diagnostics position as of Q1 2026 after selling out during the quarter.
  • Renaissance Technologies sold 24,344 Co-Diagnostics shares in Q1 2026, an estimated $123K.
  • Renaissance Technologies first reported a position in Co-Diagnostics in Q4 2019 and held it in 20 quarters.
  • Renaissance Technologies's Co-Diagnostics position peaked at $3.83M in Q2 2022.
  • 14 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.